NEUARTIGE 4-7-PEPTIDDIMERANTAGONISTEN

Patent europeic · EP2981544 · Stritgà

Inscripziun en il register

Numer da publicaziun: EP2981544
Numer da la dumonda: EP14779463
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: Stritgà
Scrittira da patent: Concedì
Annunzià: 31-03-2014
Publitgà: 10-02-2016
Concedì: 04-09-2019
Stritgà: 31-03-2020
Motiv: Taxa annuala betg pajada
Classas IPC: C07K 7/08 (2006.01)
A61K 38/10 (2006.01)
A61P 1/00 (2006.01)
Prioritad: US 201361807714 P 02.04.2013
US 201414229784 28.03.2014
Dumonda PCT: PCT/US2014/032391 31.03.2014
Publicaziun PCT: WO2014/165448 09.10.2014
Lingua da l’annunzia: englais
Funtauna: Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

21-10-2020
Stritgà, taxa betg pajada
Published in Swissreg on 21.10.2020
04-09-2019
Concedì
Published in Swissreg on 04.09.2019

Partidas

Possessur

Protagonist Therapeutics, Inc.

Protagonist Therapeutics Inc.

7707 Gateway Boulevard, Suite 140, Newark, CA 94560, US

Inventur

PATEL, Dinesh V.

Fremont, California 94539, US

BHANDARI, Ashok

Pleasanton, California 94588, US

MATTHEAKIS, Larry C.

Cupertino, California 95104, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.